How do we teach authority in a culture where everyone’s an expert?

As one of the cornerstones of the CRAAP test to evaluate the validity and usefulness of sources, we rely on the idea of “authority” to inform our evaluation of the source, to decide if it is trustworthy. In the long history of authority, we’ve variously relied on royalty/aristocracy, the Church, professors/the University, the printed word, and the “cultural elite.” In today’s world, all knowledge is available to all people (who are literate and have access to technology) at the click of a mouse or the tap of a finger. The concept of authority has been destabilized and democratized. Credentials don’t matter. Authorities conflict with each other. All truth is just biased opinion. The distrust of historical sources of authority, along with the popularization of the idea of “fake news” and “fake news media”, coupled with the increasingly small number of people who read books, and the theory of confirmation bias, where we each inhabit our own bubble of information, have combined to create an almostan almost toxic (and certainly skewed) view of authority. Who needs authorities when I can find the “truth” on my own? I can crowd-source my answer. So how do we, as teachers of information literacy and critical thinking in the library and the composition classroom, combat this? We must change the conversation and must show students that authority still matters.. WWe will’d like to offer some practical applications and exercises you could can apply to your own classroom and to open up the conversation in ways that may be helpful and encourage students to think critically about who creates information

A multi-method investigation of the association between emotional clarity and empathy.

Higher emotional clarity, the extent to which people unambiguously identify, label, and describe their own emotions, is related to a host of positive intrapersonal factors but its relation to interpersonal factors is unexplored. We hypothesized that emotional clarity would be related to cognitive empathy (i.e., perceiving others' emotions) and to accurately understanding others' negative affect (NA), but not positive affect (PA), in the context of a stressful situation. After completing self-reports of trait emotional clarity and cognitive and affective empathy (i.e., one's emotional reaction to others), participants (N = 94 undergraduate students; i.e., perceivers) viewed a series of video clips of adults (i.e., targets) completing a stressful laboratory task in a previous research study. Before and after the stress task, targets reported their state NA and PA. While viewing the recordings, perceivers rated how they thought the targets were feeling at the corresponding time points. Correspondence between perceivers' and targets' affect ratings were used as indices of the outcome variable, performance-based cognitive empathy. As expected, self-reported emotional clarity was related to the self-reported cognitive, but not affective, empathy. Moreover, perceivers' emotional clarity was related to higher cognitive empathy for NA not PA after the stressful task. Our findings provide preliminary support for the importance of emotional clarity in the ability to accurately understand others' affective experiences, which has important interpersonal implications. (PsycINFO Database Recor

Breaking up data-enabled design: expanding and scaling up for the clinical context

Data-enabled design (DED) is a promising new methodology for designing with users from within their own context in an iterative and hands-on fashion. However, the agile and flexible qualities of the methodology do not directly translate to every context. In this article, we reflect on the design process of an intelligent ecosystem, called ORBIT, and a proposed eval- uative study planned with it. This was part of a DED project in collaboration with a medical hospital to study the post-operative behavior in the (remote) context of bariatric patients. The design and preparation of this project and the process towards an eventual study rejection from the medical ethical committee (METC) provide rich insights into (1) what it means to conduct DED research in a clinical context, and (2) where the boundaries of the method might lie in this specific application area. We highlight insights from carefully designing the substantial infrastructure for the study, and how different aspects of DED translated less easily to the clinical context. We analyze the proposed study setup through the lenses of several modifications we made to DED and further reflect on how to expand and scale up the methodology and adapt the process for the clinical context

Hyperbaric oxygen brain injury treatment (HOBIT) trial: a multifactor design with response adaptive randomization and longitudinal modeling

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/134231/1/pst1755_am.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/134231/2/pst1755.pd

Bayesian hierarchical EMAX model for doseâ response in early phase efficacy clinical trials

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/149669/1/sim8167_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/149669/2/sim8167.pd

Autoantibodies and cancer among asbestos-exposed cohorts in Western Australia

Asbestos exposure is associated with many adverse health conditions including malignant mesothelioma and lung cancer as well as production of autoantibodies. Autoantibodies may serve as biomarkers for asbestos exposure in patients with cancer, and autoimmune dysfunction has been linked to increased rates of various cancers. The aim of this study was to examine the hypothesis that autoantibodies are more frequent in asbestos-exposed individuals with either lung cancer or mesothelioma than those without these conditions. Asbestos-exposed individuals from Western Australia who had lung cancer (n = 24), malignant mesothelioma (n = 24), or no malignancy (n = 51) were tested for antinuclear autoantibodies (ANA) using indirect immunofluorescence and specific extractable nuclear autoantibodies (ENA) employing a multiplexed addressable laser bead immunoassay. Contrary to the hypothesis, data demonstrated that individuals without malignancy were more likely to be positive for ANA compared to those with cancer. However, autoantibodies to histone and Ro-60 were found to be associated with lung cancer. These results support a possible predictive value for specific autoantibodies in the early detection of lung cancer and/or in our understanding of the role of autoimmune processes in cancer. However, further studies are needed to identify specific target antigens for the antibodies

Equipping Health Professions Educators to Better Address Medical Misinformation

As part of a cooperative agreement with the US Centers for Disease Control and Prevention (Federal Award Identification Number [FAIN]: NU50CK000586), the Association of American Medical Colleges (AAMC) began a strategic initiative in 2022 both to increase confidence in COVID-19 vaccines and to address medical misinformation and mistrust through education in health professions contexts. Specifically, the AAMC solicited proposals for integrating competency-based, interprofessional strategies to mitigate health misinformation into new or existing curricula. Five Health Professions Education Curricular Innovations subgrantees received support from the AAMC in 2022 and reflected on the implementation of their ideas in a series of meetings over several months. Subgrantees included the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Florida International University Herbert Wertheim College of Medicine, the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, the Maine Medical Center/Tufts University School of Medicine, and the University of Chicago Pritzker School of Medicine. This paper comprises insights from each of the teams and overarching observations regarding the challenges and opportunities involved with leveraging health professions education to address medical misinformation and improve patient health

Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B [Letter]

Members of the killer cell immunoglobulin-like receptor (KIR) family, a large group of polymorphic receptors expressed on natural killer (NK) cells, recognize particular peptide-laden human leukocyte antigen (pHLA) class I molecules and have a pivotal role in innate immune responses1. Allelic variation and extensive polymorphism within the three-domain KIR family (KIR3D, domains D0–D1–D2) affects pHLA binding specificity and is linked to the control of viral replication and the treatment outcome of certain haematological malignancies1, 2, 3. Here we describe the structure of a human KIR3DL1 receptor bound to HLA-B*5701 complexed with a self-peptide. KIR3DL1 clamped around the carboxy-terminal end of the HLA-B*5701 antigen-binding cleft, resulting in two discontinuous footprints on the pHLA. First, the D0 domain, a distinguishing feature of the KIR3D family, extended towards β2-microglobulin and abutted a region of the HLA molecule with limited polymorphism, thereby acting as an ‘innate HLA sensor’ domain. Second, whereas the D2–HLA-B*5701 interface exhibited a high degree of complementarity, the D1–pHLA-B*5701 contacts were suboptimal and accommodated a degree of sequence variation both within the peptide and the polymorphic region of the HLA molecule. Although the two-domain KIR (KIR2D) and KIR3DL1 docked similarly onto HLA-C4, 5 and HLA-B respectively, the corresponding D1-mediated interactions differed markedly, thereby providing insight into the specificity of KIR3DL1 for discrete HLA-A and HLA-B allotypes. Collectively, in association with extensive mutagenesis studies at the KIR3DL1–pHLA-B*5701 interface, we provide a framework for understanding the intricate interplay between peptide variability, KIR3D and HLA polymorphism in determining the specificity requirements of this essential innate interaction that is conserved across primate species

Influencing subjective well-being for business and sustainable development using big data and predictive regression analysis

YesBusiness leaders and policymakers within service economies are placing greater emphasis on well-being, given the role of workers in such settings. Whilst people’s well-being can lead to economic growth, it can also have the opposite effect if overlooked. Therefore, enhancing subjective well-being (SWB) is pertinent for all organisations for the sustainable development of an economy. While health conditions were previously deemed the most reliable predictors, the availability of data on people’s personal lifestyles now offers a new dimension into well-being for organisations. Using open data available from the national Annual Population Survey in the UK, which measures SWB, this research uncovered that among several independent variables to predict varying levels of people's perceived well-being, long-term health conditions, one's marital status, and age played a key role in SWB. The proposed model provides the key indicators of measuring SWB for organisations using big data

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two

Background The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd. Methods We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background. Results First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001). Conclusions In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival